Search

everythinglearnresearchcommunity

for

Search:↓

Microneedles are effective for painless drug delivery and promoting wound healing and tissue regeneration.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

Lack of Ctip2 in skin cells delays wound healing and disrupts hair follicle stem cell markers in mice.

Human Schwann cells can be quickly made from hair follicle stem cells for nerve repair.

Disrupting β-catenin signaling in certain cells causes anorectal malformations.

Hair follicle stem cells can become motor neurons and reduce muscle loss after nerve injury.

Alternative treatments show promise for hair growth beyond traditional methods.

Hair transplantation is the best treatment for hair loss, with new technologies improving results, and stem cell and gene therapies may treat severe baldness in the future.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

Researchers found a way to create cells from stem cells that act like human cells important for hair growth and could be used for hair regeneration treatments.

Mice with human gene experienced hair loss when treated with DHT.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Most skin rashes in rheumatoid arthritis patients were not caused by their medication, and careful evaluation allowed most to keep taking their beneficial treatment.

Researchers created a mouse cell line to study hair growth and test hair growth drugs.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Methotrexate side effects vary by race and sex.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

A patient lost all their hair while on rheumatoid arthritis medication.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Dermal EZH2 controls skin cell development and hair growth in mice.